Key facts
- machineMD’s last known valuation is $13.3M (Mar 2025).
- It has raised $8.0M; the latest was Later Stage VC ($3.1M) in Mar 2025.
- Notable investors include Matter (Consulting Services (B2B)), Arcanys Ventures, Bern Economic Development Agency, DayOne Accelerator, Guido Fluri Foundation — 11 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for machineMD
- ·The full record, as it builds
Funding rounds
No funding rounds for machineMD are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About machineMD
Developer of an automated medical device designed to radically improve the measurement of brain function. The company offers non-invasive equipment for the automated and quantitative assessment of eye movements, pupils, and visual fields, enabling patients to receive an accurate and early diagnosis of brain disorders.
- Sector
- Healthcare
- HQ
- Bern, Switzerland
- Founded
- 2019
- Employees
- 33
- Website
- machinemd.com/
- Ownership
- Privately Held (backing)
machineMD doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in machineMD shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on machineMD in its N-PORT filings yet. We sweep new filings monthly.